☆ 4.7 Editorial Material

REFINEMENT OF THE CLINICAL PHENOTYPE INMUSK-RELATED CONGENITAL MYASTHENIC SYNDROMES

NEUROLOGY (2009)

Journal

NEUROLOGY

Volume 73, Issue 22, Pages 1926-1928

Publisher

LIPPINCOTT WILLIAMS & WILKINS

DOI: 10.1212/WNL.0b013e3181c3fce9

Keywords

-

Categories

Clinical Neurology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Clinical Neurology

The clinical and molecular landscape of congenital myasthenic syndromes in Austria: a nationwide study

Martin Krenn, Merve Sener, Jakob Rath, Gudrun Zulehner, Omar Keritam, Matias Wagner, Franco Laccone, Stephan Iglseder, Sonja Marte, Manuela Baumgartner, Astrid Eisenkolbl, Christian Liechtenstein, Sabine Rudnik, Stefan Quasthoff, Susanne Grinzinger, Johannes Spenger, Saskia B. Wortmann, Wolfgang N. Loscher, Fritz Zimprich, Anna Kellersmann, Mika Rappold, Gunther Bernert, Michael Freilinger, Hakan Cetin

Summary: By studying the clinical and molecular characteristics of CMS patients in Austria, this research provides prevalence estimates and genotype-phenotype correlations, which can contribute to improved diagnostic approaches and patient management.

JOURNAL OF NEUROLOGY (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review

Kinji Ohno, Bisei Ohkawara, Xin-Ming Shen, Duygu Selcen, Andrew G. Engel

Summary: Congenital myasthenic syndromes (CMS) are a group of heterogeneous disorders characterized by impaired neuromuscular signal transmission due to germline pathogenic variants in genes expressed at the neuromuscular junction (NMJ). A total of 35 genes have been reported in CMS, which can be classified into 14 groups based on the pathomechanical, clinical, and therapeutic features of CMS patients. Diagnosing CMS requires measurement of compound muscle action potentials elicited by repetitive nerve stimulation, and accurate diagnosis always requires genetic studies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Clinical Neurology

Recessive VAMP1 mutations associated with severe congenital myasthenic syndromes-A recognizable clinical phenotype

Kiran Polavarapu, Seena Vengalil, Veeramani Preethish-Kumar, Gautham Arunachal, Saraswati Nashi, Dhaarini Mohan, Tanushree Chawla, Mainak Bardhan, Bevinahalli Nandeesh, Priya Gupta, Vykuntaraju K. Gowda, Hanns Lochmuller, Atchayaram Nalini

Summary: Three unrelated girls with VAMP1 mutations causing CMS, one showing prominent ocular and bulbar symptoms, while the other two had no initial ocular signs. Early genetic diagnosis is crucial for identifying potentially treatable CMS phenotypes.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Delayed Diagnosis of Congenital Myasthenic Syndromes Erroneously Interpreted as Mitochondrial Myopathies

Mariana I. Munoz-Garcia, Maria Paz Guerrero-Molina, Carlos Pablo de Fuenmayor-Fernandez de la Hoz, Laura Bermejo-Guerrero, Ana Arteche-Lopez, Aurelio Hernandez-Lain, Miguel A. Martin, Cristina Dominguez-Gonzalez

Summary: This study reported 3 cases of congenital myasthenic syndromes (CMS) initially misdiagnosed as primary mitochondrial myopathies (PMM). The patients presented with ptosis, external ophthalmoplegia, limb weakness, and fatigue. Early identification of CMS is crucial for effective medical treatment.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Article Clinical Neurology

Pregnancy outcomes in patients with congenital myasthenic syndromes

Karen O'Connell, Tatiana Rooney, Serareh Alabaf, Sithara Ramdas, David Beeson, Jacqueline Palace

Summary: The study found that while clinical worsening during pregnancy was common, it was rarely persistent; the majority of women with CMS can safely plan pregnancy, but they require close follow-up from neurology and obstetric teams; although no safety concerns were identified, continued medication use should be reviewed on a case-by-case basis.

MUSCLE & NERVE (2022)

Add to Collection

Article Clinical Neurology

Congenital Myasthenic Syndromes in Turkey: Clinical and Molecular Characterization of 16 Cases With Three Novel Mutations

Selcan Ozturk, Ayten Gulec, Murat Erdogan, Mikail Demir, Mehmet Canpolat, Hakan Gumus, Ahmet Okay Caglayan, Munis Dundar, Huseyin Per

Summary: This retrospective and cross-sectional study investigated the genetic diagnosis and treatment of CMS. Sixteen CMS patients were identified, including three novel mutations. The study emphasizes the importance of genetic testing in CMS and highlights a significant delay between symptom onset and genetic diagnosis. As the use of laboratory and genetic testing accelerates, more cases are expected to be reported.

PEDIATRIC NEUROLOGY (2022)

Add to Collection

Article Neurosciences

Pharmacological Treatments for Congenital Myasthenic Syndromes Caused by COLQ Mutations

Shuai Shao, Guanzhong Shi, Fang-Fang Bi, Kun Huang

Summary: This study reviewed related reports to determine the most appropriate pharmacological strategy for CMS caused by COLQ mutations. Beta-adrenergic agonists were found to be the first-line treatment option for CMS patients with COLQ mutations, while AChEIs should be avoided.

CURRENT NEUROPHARMACOLOGY (2023)

Add to Collection

Article Pediatrics

Respiratory insufficiency as a presenting symptom of congenital myasthenic syndromes

Fleur van den Udenhout, Peter Merkus, Sandra Verhaagen-van den Akker, Meyke Schouten, Corrie Erasmus, Hilde Braakman

Summary: This study aimed to raise awareness of congenital myasthenic syndromes (CMS) as a cause of respiratory insufficiency in infants and preschool children. Through a retrospective case study, it was found that five children experienced severe to life-threatening episodes of respiratory insufficiency, especially during viral infections, and were eventually diagnosed with genetically proven CMS. Treatment with pyridostigmine resulted in clinical improvement.

ACTA PAEDIATRICA (2023)

Add to Collection

Article Pediatrics

Recognising symptoms of congenital myasthenic syndromes in children: A guide for paediatricians

Lynn B. Orriens, Dilan Eker, Hilde M. H. Braakman, Peter J. F. M. Merkus, Corrie E. Erasmus

Summary: This study aimed to identify common symptoms of congenital myasthenic syndromes (CMS) in children and their manifestation, in order to aid diagnosis and early intervention. The most common symptoms observed in patients were proximal muscle weakness, ptosis, clumsy gait, difficulty eating solid foods, and recurrent respiratory tract infections. These symptoms often co-occurred and had a fluctuating character, which could be aggravated by infections or fatigue.

ACTA PAEDIATRICA (2023)

Add to Collection

Article Clinical Neurology

Clinical and genetic characterisation of a large Indian congenital myasthenic syndrome cohort

Kiran Polavarapu, Balaraju Sunitha, Ana Topf, Veeramani Preethish-Kumar, Rachel Thompson, Seena Vengalil, Saraswati Nashi, Mainak Bardhan, Sai Bhargava Sanka, Akshata Huddar, Gopikrishnan Unnikrishnan, Gautham Arunachal, Manu Santhappan Girija, Anna Porter, Yoshiteru Azuma, Paulo Jose Lorenzoni, Dipti Baskar, Ram Murthy Anjanappa, Madassu Keertipriya, Hansashree Padmanabh, Ganaraja Valakunja Harikrishna, Steve Laurie, Leslie Matalonga, Rita Horvath, Atchayaram Nalini, Hanns Lochmuller

Summary: Congenital myasthenic syndromes (CMS) are rare inherited disorders caused by gene defects associated with the neuromuscular junction. This study identified and genetically characterized a large cohort of CMS patients from India, and highlighted the geographic differences in the frequencies of various causative CMS genes. It also emphasized the increasing significance of glycosylation genes as a cause of neuromuscular junction defects.

BRAIN (2023)

Add to Collection

Article Clinical Neurology

Dominant and recessive congenital myasthenic syndromes caused by SYT2 mutations

Ricardo A. Maselli, David T. Wei, Trent S. Hodgson, Jacinda B. Sampson, Jessica Vazquez, Heather L. Smith, Peter Pytel, Michael Ferns

Summary: The recessive form of CMS caused by a SYT2 mutation showed more severe clinical manifestations than the dominant form. The dominant form likely involves a dominant-negative effect due to disruption of the dual function of synaptotagmin as a Ca2+-sensor and modulator of synaptic vesicle exocytosis.

MUSCLE & NERVE (2021)

Add to Collection

Article Clinical Neurology

Congenital myasthenic syndrome: Correlation between clinical features and molecular diagnosis

Eduardo P. Estephan, Antonio A. Zambon, Rachel Thompson, Kiran Polavarapu, Danny Jomaa, Ana Topf, Paulo V. P. Helito, Carlos O. Heise, Cristiane A. M. Moreno, Andre M. S. Silva, Joao A. Kouyoumdjian, Maria da Penha Morita, Umbertina C. Reed, Hanns Lochmuller, Edmar Zanoteli

Summary: This study focused on phenotype features and the correlation with molecular diagnosis of congenital myasthenic syndromes (CMS) patients, showing a higher chance of confirmed molecular diagnosis in group A and a lower chance in group C. It was found that some individual clinical features, alterations on biopsy, and electrophysiology can enhance the specificity for CMS diagnosis.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Add to Collection

Article Hematology

Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia

Alessandro Casini, Sylvia von Mackensen, Cristina Santoro, Claudia Djambas Khayat, Meriem Belhani, Cecil Ross, Akbar Dorgalaleh, Arshi Naz, Ekrem Unal, Magy Abdelwahab, Elise Dupuis Lozeron, Nathalie Trillot, Sophie Susen, Flora Peyvandi, Philippe de Moerloose

Summary: The study highlights the severe bleeding and thrombotic phenotype of afibrinogenemia and its impact on health-related quality of life. Younger age, residence in Asia or Africa, and a previous thrombotic event are statistically correlated with a worse HRQoL. Further research is needed to determine the optimal strategy for fibrinogen supplementation.

BLOOD (2021)

Add to Collection

Article Clinical Neurology

Mutations in PTPN11 could lead to a congenital myasthenic syndrome phenotype: a Noonan syndrome case series

Alessia Pugliese, Adela Della Marina, Eduardo de Paula Estephan, Edmar Zanoteli, Andreas Roos, Ulrike Schara-Schmidt, Andreas Hentschel, Yoshiteru Azuma, Ana Topf, Rachel Thompson, Kiran Polavarapu, Hanns Lochmueller

Summary: The RASopathies are a group of rare genetic diseases caused by mutations in genes involved in the RAS/MAPK pathway. PTPN11 pathogenic variants are associated with Noonan syndrome (NS) and Leopard syndrome (LPRD1), which share some clinical features. Recent studies have shown that patients with these syndromes also have motor impairment and decreased muscle strength. The exact cause of muscle involvement is still unclear, but the RAS/MAPK pathway is known to play a role in skeletal muscle development and neuromuscular junction function. Therefore, NS or LPDR1 should be considered in children with suspected congenital myasthenic syndrome (CMS) but no known CMS gene mutations, or additional symptoms indicative of NS.

JOURNAL OF NEUROLOGY (2023)

Add to Collection

Article Genetics & Heredity

Expanding the Phenotype of B3GALNT2-Related Disorders

Erika D'haenens, Sarah Vergult, Bjorn Menten, Annelies Dheedene, R. Frank Kooy, Bert Callewaert

Summary: Dystroglycanopathies are a group of congenital muscular dystrophies that show a wide range of phenotypes. They are not only clinically heterogeneous but also genetically heterogeneous. This study identifies a novel mutation in the B3GALNT2 gene associated with CMDs. Through a study on uniparental disomy, a unique case is discovered. Additionally, an overview of previously reported cases is provided, expanding the phenotypic spectrum.

GENES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact

Hanns Lochmueller, Josep Torrent i Farnell, Yann Le Cam, Anneliene H. Jonker, Lilian P. L. Lau, Gareth Baynam, Petra Kaufmann, Hugh J. S. Dawkins, Paul Lasko, Christopher P. Austin, Kym M. Boycott

EUROPEAN JOURNAL OF HUMAN GENETICS (2017)

Add to Collection

Article Clinical Neurology

A multi-source approach to determine SMA incidence and research ready population

Ingrid E. C. Verhaart, Agata Robertson, Rebecca Leary, Grace McMacken, Kirsten Koenig, Janbernd Kirschner, Cynthia C. Jones, Suzanne F. Cook, Hanns Lochmueller

JOURNAL OF NEUROLOGY (2017)

Add to Collection

Article Clinical Neurology

Congenital myasthenic syndrome with episodic apnoea: clinical, neurophysiological and genetic features in the long-term follow-up of 19 patients

Grace McMacken, Roger G. Whittaker, Teresinha Evangelista, Angela Abicht, Marina Dusl, Hanns Lochmuller

JOURNAL OF NEUROLOGY (2018)

Add to Collection

Article Pediatrics

Prevalence of epilepsy in 74,949 school children in Khartoum State, Sudan

Inaam N. Mohamed, Maha A. Elseed, Ahlam A. Hamed, Manar E. Abdel-Rahman, Sarah M. El-Sadig, Ilham M. Omer, Abdelgadir H. Osman, Ammar E. Ahmed, Zein A. Karrar, Mustafa A. Salih

PAEDIATRICS AND INTERNATIONAL CHILD HEALTH (2017)

Add to Collection

Review Clinical Neurology

Duchenne muscular dystrophy and caregiver burden: a systematic review

Erik Landfeldt, Josefin Edstroem, Filippo Buccella, Janbernd Kirschner, Hanns Lochmueller

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2018)

Add to Collection

Review Biochemistry & Molecular Biology

RD-Connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases

Hanns Lochmueller, Dorota M. Badowska, Rachel Thompson, Nine V. Knoers, Annemieke Aartsma-Rus, Ivo Gut, Libby Wood, Tina Harmuth, Andre Durudas, Holm Graessner, Franz Schaefer, Olaf Riess

EUROPEAN JOURNAL OF HUMAN GENETICS (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Neuromuscular Junction Changes in a Mouse Model of Charcot-Marie-Tooth Disease Type 4C

Silvia Cipriani, Vietxuan Phan, Jean-Jacques Medard, Rita Horvath, Hanns Lochmueller, Roman Chrast, Andreas Roos, Sally Spendiff

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Add to Collection

Article Cell Biology

MACF1 links Rapsyn to microtubule- and actin-binding proteins to maintain neuromuscular synapses

Julien Oury, Yun Liu, Ana Topf, Slobodanka Todorovic, Esthelle Hoedt, Veeramani Preethish-Kumar, Thomas A. Neubert, Weichun Lin, Hanns Lochmueller, Steven J. Burden

JOURNAL OF CELL BIOLOGY (2019)

Add to Collection

Article Genetics & Heredity

Increasing phenotypic annotation improves the diagnostic rate of exome sequencing in a rare neuromuscular disorder

Rachel Thompson, Anastasios Papakonstantinou Ntalis, Sergi Beltran, Ana Topf, Eduardo de Paula Estephan, Kiran Polavarapu, Peter A. C't Hoen, Paolo Missier, Hanns Lochmuller

HUMAN MUTATION (2019)

Add to Collection

Article Geriatrics & Gerontology

Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy

Mirko Signorelli, Burcu Ayoglu, Camilla Johansson, Hanns Lochmueller, Volker Straub, Francesco Muntoni, Erik Niks, Roula Tsonaka, Anja Persson, Annemieke Aartsma-Rus, Peter Nilsson, Cristina Al-Khalili Szigyarto, Pietro Spitali

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)

Add to Collection

Article Pediatrics

Acute Necrotizing Encephalopathy of Childhood: A Multicenter Experience in Saudi Arabia

Fahad A. Bashiri, Sultan Al Johani, Muddathir H. Hamad, Amal Y. Kentab, Ali H. Alwadei, Khalid Hundallah, Hamdi H. Hasan, Walaa Alshuaibi, Lamyaa Jad, Muhammad Talal Alrifai, Abrar Hudairi, Rana Al Sheikh, Asma'a Alenizi, Nawaf A. Alharthi, Tayseer A. Abdelmagid, Duaa Ba-Armah, Mustafa A. Salih, Brahim Tabarki

FRONTIERS IN PEDIATRICS (2020)

Add to Collection

Letter Genetics & Heredity

Disease monitoring programs of rare genetic diseases: transparent data sharing between academic and commercial stakeholders

Hanns Lochmueller, Antonio Nino Ramirez, Emil Kakkis

Summary: The suggestion to form registries for rare neuromuscular diseases exclusively governed by physicians and patients aims to limit conflicts of interest, but poses logistical and financial challenges. An alternative proposed is the use of Disease Monitoring Programs (DMPs) for post-marketing follow-up, involving all stakeholders and ensuring consistent data collection and governance.

ORPHANET JOURNAL OF RARE DISEASES (2021)

Add to Collection

Article Neurosciences

Congenital myasthenic syndrome in a cohort of patients with 'double' seronegative myasthenia gravis

Paulo Jose Lorenzoni, Renata Dal-Pra Ducci, Raquel Cristina Arndt, Nyvia Milicio Coblinski Hrysay, Otto Jesus Hernandez Fustes, Ana Topf, Hanns Lochmuller, Lineu Cesar Werneck, Claudia Suemi Kamoi Kay, Rosana Herminia Scola

Summary: This study confirmed that CMS caused by CHNRE mutations can be mistaken for SNMG, with an estimated misdiagnosis rate of 4.5% in 'double' SNMG patients in a Brazilian center. Genetic screening may be helpful in the diagnostic workup of 'double' SNMG patients.

ARQUIVOS DE NEURO-PSIQUIATRIA (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Clinical phenotyping and genetic diagnosis of a large cohort of Sudanese families with hereditary spinocerebellar degenerations

Ashraf Yahia, Ahlam A. A. Hamed, Inaam N. Mohamed, Maha A. Elseed, Mustafa A. Salih, Sarah M. El-Sadig, Hassab Elrasoul Siddig, Ali Elsir Musa Nasreldien, Mohamed Ahmed Abdullah, Maha Elzubair, Farouk Yassen Omer, Aisha Motwakil Bakhiet, Rayan Abubaker, Fatima Abozar, Rawaa Adil, Sara Emad, Mhammed Alhassan Musallam, Isra Z. M. Eltazi, Zulfa Omer, Hiba Malik, Mayada O. E. Mohamed, Ali A. Elhassan, Eman O. E. Mohamed, Ahmed K. M. A. Ahmed, Elhami A. A. Ahmed, Esraa Eltaraifee, Bidour K. Hussein, Amal S. I. Abd Allah, Lina Salah, Mohamed Nimir, Omnia M. Tag Elseed, Tasneem E. A. Elhassan, Abubakr Elbashier, Esraa S. A. Alfadul, Moneeb Fadul, Khalil F. Ali, Shaimaa Omer M. A. Taha, Elfatih E. Bushara, Mutaz Amin, Mahmoud Koko, Muntaser E. Ibrahim, Ammar E. Ahmed, Liena E. O. Elsayed, Giovanni Stevanin

Summary: Hereditary spinocerebellar degenerations (SCDs) are a group of monogenic conditions that include hereditary spastic paraplegia (HSP), cerebellar ataxia, and spinocerebellar ataxia. They often overlap with other neurological conditions and are caused by more than 200 genes and loci inherited through various modes of inheritance. Sudanese families with high consanguinity rates were studied, and a genetic diagnosis was reached in 63-73% of the families.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Add to Collection

Meeting Abstract Clinical Neurology

PATHOGENIC VARIANTS IN KCTD7 PERTURB NEURONAL K plus FLUXES AND GLUTAMINE TRANSPORT

M. N. Moen, R. Fajaer, H. El Hassan, H. El Khashab, M. A. Salih, F. A. Chaudhry

EPILEPSIA (2017)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.